FGF6 enhances muscle regeneration after nerve injury by relying on ERK1/2 mechanism
Autor: | Biao Cheng, Cai Qiuchen, Heng’an Ge, Wu Peng, Min Zhu, Sudan Xu, Qing'’gang Zhang, Chao Xue, Genbin Wu |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Male Fibroblast Growth Factor 6 Primary Cell Culture MyoD 030226 pharmacology & pharmacy General Biochemistry Genetics and Molecular Biology Cell Line Myoblasts Rats Sprague-Dawley 03 medical and health sciences 0302 clinical medicine Cell Movement Peripheral Nerve Injuries medicine Myocyte Animals Regeneration Cyclin D1 Receptor Fibroblast Growth Factor Type 4 Receptor Fibroblast Growth Factor Type 1 General Pharmacology Toxicology and Pharmaceutics RNA Small Interfering Muscle Skeletal Myogenin Cell Proliferation MyoD Protein Denervation Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Myosin Heavy Chains Chemistry Skeletal muscle Cell Differentiation General Medicine Nerve injury musculoskeletal system Sciatic Nerve Muscle Denervation Cell biology Rats 030104 developmental biology medicine.anatomical_structure Gene Expression Regulation Peripheral nerve injury medicine.symptom tissues C2C12 |
Zdroj: | Life sciences. 248 |
ISSN: | 1879-0631 |
Popis: | Background Severe peripheral nerve injury leads to skeletal muscle atrophy and impaired limb function that is not sufficiently improved by existing treatments. Fibroblast growth factor 6 (FGF6) is involved in tissue regeneration and is dysregulated in denervated rat muscles. However, the way that FGF6 affects skeletal muscle repair after peripheral nerve injury has not been fully elucidated. Methods In this study, we investigated the role of FGF6 in the regeneration of denervated muscles using myoblast cells and an in vivo model of peripheral nerve injury. Results FGF6 promoted the viability and migration of C2C12 and primary myoblasts in a dose-dependent manner through FGFR1-mediated upregulation of cyclin D1. Low concentrations of FGF6 promoted myoblast differentiation through FGFR4-mediated activation of ERK1/2, which upregulated expression of MyHC, MyoD, and myogenin. FGFR-1, FGFR4, MyoD, and myogenin were not upregulated when FGF6 expression was inhibited in myoblasts by shRNA-mediated knockdown. Injection of FGF6 into denervated rat muscles enhanced the MyHC-IIb muscle fiber phenotype and prevented muscular atrophy. Conclusion These findings indicate that FGF6 reduces skeletal muscle atrophy by relying on the ERK1/2 mechanism and enhances the conversion of slow muscle to fast muscle fibers, thereby promoting functional recovery of regenerated skeletal muscle after innervation. |
Databáze: | OpenAIRE |
Externí odkaz: |